{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:14:42Z","timestamp":1794060882648,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01273-4","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:01:49Z","timestamp":1782770509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Whole-Body Pharmacokinetics of Ionizable Lipid, mRNA, and the Expressed Antibody following Intravenous Administration of mRNA-Loaded Lipid Nanoparticles"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1243-3018","authenticated-orcid":false,"given":"Shrusti","family":"Tiwari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8424-8123","authenticated-orcid":false,"given":"Mokshada","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7213-9554","authenticated-orcid":false,"given":"Shengjia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7388-4425","authenticated-orcid":false,"given":"Rutuja","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0723-6206","authenticated-orcid":false,"given":"Dhaval K.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"1","key":"1273_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12929-024-01080-z","volume":"31","author":"R-M Lu","year":"2024","unstructured":"Lu R-M, Hsu H-E, Perez SJLP, Kumari M, Chen G-H, Hong M-H, et al. Current landscape of mRNA technologies and delivery systems for new modality therapeutics. J Biomed Sci. 2024;31(1):89.","journal-title":"J Biomed Sci"},{"issue":"27","key":"1273_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603\u201315.","journal-title":"N Engl J Med"},{"issue":"1","key":"1273_CR3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11095-022-03166-5","volume":"39","author":"J Di","year":"2022","unstructured":"Di J, Du Z, Wu K, Jin S, Wang X, Li T, et al. Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size. Pharm Res. 2022;39(1):105\u201314.","journal-title":"Pharm Res"},{"issue":"1","key":"1273_CR4","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","volume":"9","author":"Y Shi","year":"2024","unstructured":"Shi Y, Shi M, Wang Y, You J. Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications. Signal Transduct Target Ther. 2024;9(1):322.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"1273_CR5","doi-asserted-by":"publisher","first-page":"14630","DOI":"10.1038\/ncomms14630","volume":"8","author":"N Pardi","year":"2017","unstructured":"Pardi N, Secreto AJ, Shan X, Debonera F, Glover J, Yi Y, et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017;8(1):14630.","journal-title":"Nat Commun"},{"issue":"1","key":"1273_CR6","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1186\/s12967-023-04553-1","volume":"21","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Gan L, Ke D, Chen Q, Fu Y. Mechanisms and research advances in mRNA antibody drug-mediated passive immunotherapy. J Transl Med. 2023;21(1):693.","journal-title":"J Transl Med"},{"issue":"1","key":"1273_CR7","doi-asserted-by":"publisher","first-page":"3999","DOI":"10.1038\/s41467-018-06508-3","volume":"9","author":"PM Tiwari","year":"2018","unstructured":"Tiwari PM, Vanover D, Lindsay KE, Bawage SS, Kirschman JL, Bhosle S, et al. Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection. Nat Commun. 2018;9(1):3999.","journal-title":"Nat Commun"},{"issue":"1","key":"1273_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2023.2255041","volume":"12","author":"H B\u00e4hr-Mahmud","year":"2023","unstructured":"B\u00e4hr-Mahmud H, Ellinghaus U, Stadler CR, Fischer L, Lindemann C, Chaturvedi A, et al. Preclinical characterization of an mRNA-encoded anti-Claudin 18.2 antibody. Oncoimmunology. 2023;12(1):2255041.","journal-title":"Oncoimmunology"},{"issue":"2","key":"1273_CR9","doi-asserted-by":"publisher","first-page":"102175","DOI":"10.1016\/j.omtn.2024.102175","volume":"35","author":"H Parhiz","year":"2024","unstructured":"Parhiz H, Shuvaev VV, Li Q, Papp TE, Akyianu AA, Shi R, et al. Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Molecular Therapy - Nucleic Acids. 2024;35(2):102175.","journal-title":"Molecular Therapy - Nucleic Acids"},{"issue":"8","key":"1273_CR10","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ymthe.2019.05.012","volume":"27","author":"Y Rybakova","year":"2019","unstructured":"Rybakova Y, Kowalski PS, Huang Y, Gonzalez JT, Heartlein MW, DeRosa F, et al. mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo. Mol Ther. 2019;27(8):1415\u201323.","journal-title":"Mol Ther"},{"issue":"1","key":"1273_CR11","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.xphs.2020.05.025","volume":"110","author":"HP Chang","year":"2021","unstructured":"Chang HP, Kim SJ, Shah DK. Whole-Body Pharmacokinetics of Antibody in Mice Determined using Enzyme-Linked Immunosorbent Assay and Derivation of Tissue Interstitial Concentrations. J Pharm Sci. 2021;110(1):446\u201357.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1273_CR12","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s41467-025-57488-0","volume":"16","author":"X Bian","year":"2025","unstructured":"Bian X, Guo Q, Yau L-F, Yang L, Wang X, Zhao S, et al. Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics. Nat Commun. 2025;16(1):2368.","journal-title":"Nat Commun"},{"issue":"2","key":"1273_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.4161\/mabs.23684","volume":"5","author":"DK Shah","year":"2013","unstructured":"Shah DK, Betts AM. Antibody biodistribution coefficients. MAbs. 2013;5(2):297\u2013305.","journal-title":"MAbs"},{"issue":"1","key":"1273_CR14","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1038\/s41467-025-57488-0","volume":"16","author":"X Bian","year":"2025","unstructured":"Bian X, Guo Q, Yau L-F, Yang L, Wang X, Zhao S, et al. Berberine-inspired ionizable lipid for self-structure stabilization and brain targeting delivery of nucleic acid therapeutics. Nat Commun. 2025;16(1):2368.","journal-title":"Nat Commun"},{"issue":"7","key":"1273_CR15","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/mt.2010.85","volume":"18","author":"A Akinc","year":"2010","unstructured":"Akinc A, Querbes W, De S, Qin J, Frank-Kamenetsky M, Jayaprakash KN, et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol Ther. 2010;18(7):1357\u201364.","journal-title":"Mol Ther"},{"key":"1273_CR16","doi-asserted-by":"publisher","unstructured":"Luo J, Molbay M, Chen Y, et al. Nanocarrier imaging at single-cell resolution across entire mouse bodies withdeep learning. Nat Biotechnol. 2025;43(12):2009-2022. https:\/\/doi.org\/10.1038\/s41587-024-02528-1.","DOI":"10.1038\/s41587-024-02528-1"},{"issue":"8","key":"1273_CR17","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1073\/pnas.1620874114","volume":"114","author":"JE Dahlman","year":"2017","unstructured":"Dahlman JE, Kauffman KJ, Xing Y, Shaw TE, Mir FF, Dlott CC, et al. Barcoded nanoparticles for high throughput in vivo discovery of targeted therapeutics. Proc Natl Acad Sci. 2017;114(8):2060\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"1273_CR18","doi-asserted-by":"publisher","unstructured":"Dilliard SA, Cheng Q, Siegwart DJ. On the mechanism of tissue-specifi c mRNA delivery by selective organtargeting nanoparticles. Proc Natl Acad Sci U S A. 2021;118(52):e2109256118. https:\/\/doi.org\/10.1073\/pnas.2109256118.","DOI":"10.1073\/pnas.2109256118"},{"issue":"2","key":"1273_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol. 2010;28(2):172\u20136.","journal-title":"Nat Biotechnol"},{"key":"1273_CR20","unstructured":"European Medicines Agency (EMA). Assessment report: Comirnaty (COVID-19 mRNA vaccine [nucleoside-modified]).2021. (EMEA\/H\/C\/005735\/0000)."},{"issue":"6","key":"1273_CR21","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","volume":"26","author":"S Sabnis","year":"2018","unstructured":"Sabnis S, Kumarasinghe ES, Salerno T, Mihai C, Ketova T, Senn JJ, et al. A novel amino lipid series for mRNA delivery: improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol Ther. 2018;26(6):1509\u201319.","journal-title":"Mol Ther"},{"key":"1273_CR22","doi-asserted-by":"publisher","unstructured":"Pateev I, Seregina K, Ivanov R, Reshetnikov V. Biodistribution of RNA Vaccines and of Their Products: Evidencefrom Human and Animal Studies. Biomedicines. 2023;12(1):59. https:\/\/doi.org\/10.3390\/biomedicines12010059.","DOI":"10.3390\/biomedicines12010059"},{"issue":"12","key":"1273_CR23","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078\u201394.","journal-title":"Nat Rev Mater"},{"issue":"11","key":"1273_CR24","doi-asserted-by":"publisher","first-page":"8392","DOI":"10.1021\/acsnano.3c13039","volume":"18","author":"ND Le","year":"2024","unstructured":"Le ND, Nguyen BL, Patil BR, Chun H, Kim S, Nguyen TOO, et al. Antiangiogenic therapeutic mRNA delivery using lung-selective polymeric nanomedicine for lung cancer treatment. ACS Nano. 2024;18(11):8392\u2013410.","journal-title":"ACS Nano"},{"issue":"3","key":"1273_CR25","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ymthe.2025.01.008","volume":"33","author":"M Buckley","year":"2025","unstructured":"Buckley M, Arainga M, Maiorino L, Pires IS, Kim BJ, Michaels KK, et al. Visualizing lipid nanoparticle trafficking for mRNA vaccine delivery in non-human primates. Mol Ther. 2025;33(3):1105\u201317.","journal-title":"Mol Ther"},{"issue":"4","key":"1273_CR26","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1039\/D4PM00128A","volume":"1","author":"C McMillan","year":"2024","unstructured":"McMillan C, Druschitz A, Rumbelow S, Borah A, Binici B, Rattray Z, et al. Tailoring lipid nanoparticle dimensions through manufacturing processes. RSC Pharm. 2024;1(4):841\u201353.","journal-title":"RSC Pharm"},{"issue":"34","key":"1273_CR27","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman M, Ansell SM, Mui BL, Tam YK, Chen J, Du X, et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem Int Ed Engl. 2012;51(34):8529\u201333.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"4","key":"1273_CR28","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41565-024-01847-3","volume":"20","author":"SRJ Hofstraat","year":"2025","unstructured":"Hofstraat SRJ, Anbergen T, Zwolsman R, Deckers J, van Elsas Y, Trines MM, et al. Nature-inspired platform nanotechnology for RNA delivery to myeloid cells and their bone marrow progenitors. Nat Nanotechnol. 2025;20(4):532\u201342.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"1273_CR29","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1038\/s41467-025-58523-w","volume":"16","author":"MHY Cheng","year":"2025","unstructured":"Cheng MHY, Zhang Y, Fox K, Leung J, Strong C, Kang E, et al. Liposomal lipid nanoparticles for extrahepatic delivery of mRNA. Nat Commun. 2025;16(1):4135.","journal-title":"Nat Commun"},{"issue":"1","key":"1273_CR30","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10928-011-9232-2","volume":"39","author":"DK Shah","year":"2012","unstructured":"Shah DK, Betts AM. Towards a platform PBPK model to characterize the plasma and tissue disposition of monoclonal antibodies in preclinical species and human. J Pharmacokinet Pharmacodyn. 2012;39(1):67\u201386.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"10","key":"1273_CR31","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1016\/j.apsb.2024.06.011","volume":"14","author":"W Wang","year":"2024","unstructured":"Wang W, Deng S, Lin J, Ouyang D. Modeling on in vivo disposition and cellular transportation of RNA lipid nanoparticles via quantum mechanics\/physiologically-based pharmacokinetic approaches. Acta Pharm Sin B. 2024;14(10):4591\u2013607.","journal-title":"Acta Pharm Sin B"},{"key":"1273_CR32","doi-asserted-by":"publisher","first-page":"1330406","DOI":"10.3389\/fnano.2024.1330406","volume":"6","author":"K Miyazawa","year":"2024","unstructured":"Miyazawa K, Liu Y, Bazzazi H. Development of a minimal PBPK-QSP modeling platform for LNP-mRNA based therapeutics to study tissue disposition and protein expression dynamics. Frontiers in Nanotechnology. 2024;6:1330406.","journal-title":"Front Nanotechnol"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01273-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:16:49Z","timestamp":1785521809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01273-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01273-4","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"8 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"119"}}